NP48925b Hereditary Angioedema Branded Medicines (Berinert)
Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£4,733,292
Published
2 May 2025
Closes
2 May 2025
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 NP48925b Hereditary Angioedema Branded Medicines (Berinert)
£4,733,292
The Framework Agreement is for the supply of hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Delivery: Scotland
Documents
Unlock document linkNP48925b Hereditary Angioedema Branded Medicines (Berinert)
Not provided
Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland.
Award notice · Web page
NP48925b Hereditary Angioedema Branded Medicines (Berinert)
Not provided
Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.